Market Place
Sourcing Support
J&J finds another path for Momenta drug in rare fetal disorder
07 Feb 2023 //
FIERCE BIOTECH
J&J, Momenta Pharma file patent infringement lawsuit against Natco, Mylan
26 May 2022 //
BUSINESS-STANDARD
Provention hires 3rd exec as it awaits FDA meeting for lead drug
18 Nov 2021 //
FIERCEBIOTECH
J&J, free from rival bidders, made Momenta wait on $6.5B deal
03 Sep 2020 //
FIERCEBIOTECH
Enthused by PhII autoimmune data, J&J kept Momenta waiting in $6.5B buyout
02 Sep 2020 //
ENDPTS
Momenta Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN
27 Jul 2020 //
GLOBENEWSWIRE
Momenta Pharma drug improves symptoms in patients with myasthenia gravis
15 Jun 2020 //
PRESS RELEASE
Momenta clears a PhII hurdle on nipo but one big rival remains well in the lead
15 Jun 2020 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.